Discussion of the R&D Models for Chinese Private Small and Medium Pharmaceutical Enterprises

OBJECTIVE To study the R&D models fit for the Chinese private small and medium pharmaceutical enterprises nowadays. METHODS Trough studying the current R&D situation of the Chinese pharmaceutical industry and private small and medium enterprises, this thesis introduced three R&D models, and analyzed their characteristics and applicability for what kinds of enterprise respectively. RESULTS The SWOT analysis showed that most of the private small and medium enterprises had behavioral advantages, but no resources advantages. Their capital, technology and human resource were insufficient. CONCLUSION According to the overall strength of private small and medium enterprises, this thesis suggests that simulating innovation strategy model would be more feasible at this stage. It can enhance the efficiency of limited resources and reduce risk. The enterprises should pay attention to the matters of research project choosing, project evaluation, patent strategy, and etc..